SCYX logo

SCYX
Scynexis Inc

10,039
Mkt Cap
$53.05M
Volume
402,638.00
52W High
$1.31
52W Low
$0.565
PE Ratio
-1.59
SCYX Fundamentals
Price
$0.71
Prev Close
$0.6678
Open
$0.66
50D MA
$0.9139
Beta
1.05
Avg. Volume
420,451.37
EPS (Annual)
-$0.1724
P/B
1.07
Rev/Employee
$1.14M
$6.36
Loading...
Loading...
News
all
press releases
News Placeholder
Poxel To Sell PXL770 To Scynexis For Up To $196 Mln; Shares Up
(RTTNews) - Poxel SA (POXEL.PA, PXXLF), a clinical-stage biopharmaceutical company, on Tuesday announced that it has agreed to sell its drug candidate PXL770 to Scynexis, Inc. (SCYX), for up to $196 million...
News Placeholder
Scynexis In Spotlight After Poxel Deal, $40 Million Private Placement – SCYX Stock Climbs 2% Pre-Market
The biotech firm announced a deal to acquire a potential treatment for a kidney disease and secured $40 million through a private placement.
News Placeholder
SCYNEXIS Q4 Earnings Assessment
read more...
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available